Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Sales | 59,276 | 39,700 | 45,190 | 33,100 | 24,113 |
| Cost of Goods | 15,566 | 3,610 | 5,000 | 0 | 1,110 |
| Gross Profit | 43,710 | 36,090 | 40,190 | 33,100 | 22,990 |
| Operating Expenses | 69,552 | 55,320 | 45,880 | 40,541 | 40,336 |
| Operating Income | -25,276 | -18,620 | -5,690 | -7,441 | -17,223 |
| Interest Expense | 281 | 280 | 420 | 734 | 939 |
| Other Income | 3,905 | -4,170 | -2,510 | -3,403 | -14,261 |
| Pre-tax Income | -21,652 | -23,070 | -8,620 | -11,578 | -32,423 |
| Net Income Continuous | -21,652 | -23,070 | -8,625 | -11,579 | -32,424 |
| Net Income | $-23,215 | $-23,070 | $-8,620 | $-11,578 | $-32,423 |
| EPS Basic Total Ops | -0.66 | -0.74 | -0.28 | -0.40 | -1.33 |
| EPS Basic Continuous Ops | -0.62 | -0.74 | -0.28 | -0.40 | -1.33 |
| EPS Diluted Total Ops | -0.66 | -0.74 | -0.28 | -0.40 | -1.33 |
| EPS Diluted Continuous Ops | -0.62 | -0.74 | -0.28 | -0.40 | -1.33 |
| EBITDA(a) | $-20,855 | $-15,200 | $-2,680 | $-3,052 | $-11,143 |